Open Date
23 Sep 2025
Close Date
25 Sep 2025
Listing Date
30 Sep 2025
Max Investment
₹8,40,000
Price Range
₹65 - ₹70
Lot Size
-
IPO Size
₹13.02Cr
Exchange Symbols


Open Date
Close Date
Listing Date
Max Investment
Price Range
Lot Size
IPO Size
Exchange Symbols
Diversified Product Portfolio.
Robust and Responsive Distribution Network.
Strategic Manufacturing Partnerships.
Commitment to High-Quality Standards.
Our Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model. We do not own any manufacturing plants but has entered into contract manufacturing agreement with seven manufacturing units. under various arrangements. Of these, we have formal loan and license agreements in place with two manufacturing units. The remaining production is carried out through informal arrangements with Other Manufacturers, based on purchase orders (PO). We provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
Aptus Pharma: IPO Dates
The Aptus Pharma IPO opens for subscription on 23 Sep 2025, and closes on 25 Sep 2025. Investors will likely receive their allotment status updates on 26 Sep 2025. Those who get allotted shares can expect them credited to their Demat accounts by 29 Sep 2025. The shares will be officially listed on the stock exchange on 30 Sep 2025.
Aptus Pharma: IPO Price Band
The IPO consists of a fresh issue and an offer for sale, with a price band set between ₹65.0 and ₹70.0 per share.Investors can apply within this range. This SME issue includes a fresh issue worth ₹13.02 crore and an offer for sale valued at ₹ - crore. The exact listing price will be revealed on 30 Sep 2025, which is when the shares start trading on the exchange.
Aptus Pharma: Lot Size and Issue Size
The minimum application lot size is shares, and investors need to apply for at least one lot. The total IPO size is approximately ₹13.02Cr crore.
You will also get notified of your allotment via push notifications and email from Torus Digital.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.